Triggering receptor expressed on myeloid cells‐2 fine‐tunes inflammatory responses in murine Gram‐negative sepsis

During infections, TLR‐mediated responses require tight regulation to allow for pathogen removal, while preventing overwhelming inflammation and immunopathology. The triggering receptor expressed on myeloid cells (TREM)‐2 negatively regulates inflammation by macrophages and impacts on phagocytosis, but the function of endogenous TREM‐2 during infections is poorly understood. We investigated TREM‐2's role in regulating TLR4‐mediated inflammation by studying wild‐type and TREM‐2‐/‐ mice challenged with LPS and found TREM‐2 to dampen early inflammation. Augmented early inflammation in TREM‐2‐/‐ animals was followed by an accelerated resolution and ultimately improved survival, associated with the induction of the negative regulator A20. Upon infection with Escherichia coli, the otherwise beneficial effect of an exaggerated early immune response in TREM‐2‐/‐ animals was counteracted by a 50% reduction in bacterial phagocytosis. In line with this, TREM‐2‐/‐ peritoneal macrophages (PMs) exhibited augmented inflammation following TLR4 stimulation, demonstrating the presence and negative regulatory functionality of TREM‐2 on primary PMs. Significantly, we identified a high turnover rate because TREM‐2 RNA is 25‐fold down‐regulated and the protein proteasomally degraded upon LPS encounter, thus ensuring a tightly regulated and versatile system that modulates inflammation. Our results illustrate TREM‐2's effects on infection‐triggered inflammation and identify TREM‐2 as a potential target to prevent overwhelming inflammation while preserving antibacterial‐effector functions.—Gawish, R., Martins, R., Böhm, B., Wimberger, T., Sharif, O., Lakovits, K., Schmidt, M., Knapp, S. Triggering receptor expressed on myeloid cells‐2 fine‐tunes inflammatory responses in murine Gram‐negative sepsis. FASEB J. 29, 1247‐1257 (2015). www.fasebj.org

[1]  H. Neumann,et al.  Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage* , 2013, The Journal of Biological Chemistry.

[2]  Qisheng Peng,et al.  A Physical Interaction Between the Adaptor Proteins DOK3 and DAP12 Is Required to Inhibit Lipopolysaccharide Signaling in Macrophages , 2013, Science Signaling.

[3]  Q. Shu,et al.  Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance. , 2013, American journal of respiratory and critical care medicine.

[4]  L. Langeberg,et al.  WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs. , 2013, The Journal of clinical investigation.

[5]  L. Hazlett,et al.  TREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway. , 2013, Investigative ophthalmology & visual science.

[6]  O. Sharif,et al.  The Scavenger Receptor CD36 Downmodulates the Early Inflammatory Response while Enhancing Bacterial Phagocytosis during Pneumococcal Pneumonia , 2013, The Journal of Immunology.

[7]  A. Matsuda,et al.  Current trends in inflammatory and immunomodulatory mediators in sepsis , 2013, Journal of leukocyte biology.

[8]  M. Genua,et al.  Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response. , 2013, Gastroenterology.

[9]  Sangdun Choi,et al.  Negative regulatory approaches to the attenuation of Toll-like receptor signaling , 2013, Experimental & Molecular Medicine.

[10]  L. Joosten,et al.  TREM‐1: intracellular signaling pathways and interaction with pattern recognition receptors , 2013, Journal of leukocyte biology.

[11]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[12]  Shizuo Akira,et al.  Dissecting negative regulation of Toll-like receptor signaling. , 2012, Trends in immunology.

[13]  Hiroaki Ito,et al.  TREM‐2, triggering receptor expressed on myeloid cell‐2, negatively regulates TLR responses in dendritic cells , 2012, European journal of immunology.

[14]  T. van der Poll,et al.  Delineation of the Role of Toll-like Receptor Signaling during Peritonitis by a Gradually Growing Pathogenic Escherichia coli , 2011, The Journal of Biological Chemistry.

[15]  J. Peter-Katalinic,et al.  Cell type-specific and site directed N-glycosylation pattern of FcγRIIIa. , 2011, Journal of proteome research.

[16]  K. Coggeshall,et al.  TREM2- and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1 , 2010, Science Signaling.

[17]  T. van der Poll,et al.  Priming of alveolar macrophages upon instillation of lipopolysaccharide in the human lung. , 2010, American journal of respiratory cell and molecular biology.

[18]  L. Ivashkiv,et al.  IL-10 Suppresses Calcium-Mediated Costimulation of Receptor Activator NF-κB Signaling during Human Osteoclast Differentiation by Inhibiting TREM-2 Expression1 , 2009, The Journal of Immunology.

[19]  Katharina,et al.  TREM-1 Activation Alters the Dynamics of Pulmonary IRAK-M Expression In Vivo and Improves Host Defense during Pneumococcal Pneumonia1 , 2009, The Journal of Immunology.

[20]  G. van Loo,et al.  The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. , 2009, Trends in immunology.

[21]  R. Beyaert,et al.  A20: Central Gatekeeper in Inflammation and Immunity* , 2009, Journal of Biological Chemistry.

[22]  D. McVicar,et al.  TREM and TREM-like receptors in inflammation and disease. , 2009, Current opinion in immunology.

[23]  M. Colonna,et al.  TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria , 2009, The Journal of cell biology.

[24]  L. Lanier.  DAP10‐ and DAP12‐associated receptors in innate immunity , 2009, Immunological reviews.

[25]  O. Sharif,et al.  From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. , 2008, Immunobiology.

[26]  Xia Zhang,et al.  The Isolation and Characterization of Murine Macrophages , 2008, Current protocols in immunology.

[27]  D. Laskin,et al.  Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. , 2008, Experimental and molecular pathology.

[28]  T. van der Poll,et al.  Oxidized Phospholipids Inhibit Phagocytosis and Impair Outcome in Gram-Negative Sepsis In Vivo1 , 2007, The Journal of Immunology.

[29]  M. Colonna,et al.  The TREM receptor family and signal integration , 2006, Nature Immunology.

[30]  A. Bauch,et al.  An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells , 2006, Nature Methods.

[31]  L. Piccio,et al.  Cutting Edge: TREM-2 Attenuates Macrophage Activation1 , 2006, The Journal of Immunology.

[32]  L. Lanier,et al.  Cutting Edge: Inhibition of TLR and FcR Responses in Macrophages by Triggering Receptor Expressed on Myeloid Cells (TREM)-2 and DAP121 , 2006, The Journal of Immunology.

[33]  J. Trowsdale,et al.  You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling , 2006, European journal of immunology.

[34]  L. Lanier,et al.  Inhibition of Immune Responses by ITAM-Bearing Receptors , 2006, Science's STKE.

[35]  F. Liew,et al.  Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.

[36]  T. van der Poll,et al.  Toll-like receptor 4 deficiency and acute pancreatitis act similarly in reducing host defense during murine Escherichia coli peritonitis , 2005, Critical care medicine.

[37]  H. Neumann,et al.  Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 , 2005, The Journal of experimental medicine.

[38]  T. van der Poll,et al.  Cutting Edge: Expression Patterns of Surface and Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Human Endotoxemia1 , 2004, The Journal of Immunology.

[39]  M. Béné,et al.  A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine Sepsis , 2004, The Journal of experimental medicine.

[40]  Matthew T Wheeler,et al.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.

[41]  M. Bianchin,et al.  Nasu–Hakola Disease (Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy—PLOSL): A Dementia Associated with Bone Cystic Lesions. From Clinical to Genetic and Molecular Aspects , 2004, Cellular and Molecular Neurobiology.

[42]  T. van der Poll,et al.  Lipopolysaccharide Binding Protein Is an Essential Component of the Innate Immune Response to Escherichia coli Peritonitis in Mice , 2003, Infection and Immunity.

[43]  C. Buonsanti,et al.  Impaired Differentiation of Osteoclasts in TREM-2–deficient Individuals , 2003, The Journal of experimental medicine.

[44]  L. Peltonen,et al.  DAP12/TREM2 Deficiency Results in Impaired Osteoclast Differentiation and Osteoporotic Features , 2003, The Journal of experimental medicine.

[45]  P. Ward,et al.  The enigma of sepsis. , 2003, The Journal of clinical investigation.

[46]  W. Seaman,et al.  Pattern Recognition by TREM-2: Binding of Anionic Ligands1 , 2003, The Journal of Immunology.

[47]  Charles A. Janeway,et al.  IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.

[48]  Charles A. Janeway,et al.  Decoding the Patterns of Self and Nonself by the Innate Immune System , 2002, Science.

[49]  C. Ferran,et al.  A20 protects mice from D‐galactosamine/lipopolysaccharide acute toxic lethal hepatitis , 2002, Hepatology.

[50]  M. Colonna,et al.  A Dap12-Mediated Pathway Regulates Expression of Cc Chemokine Receptor 7 and Maturation of Human Dendritic Cells , 2001, The Journal of experimental medicine.

[51]  M. Colonna,et al.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.

[52]  J. Tellado,et al.  Defense mechanisms of the peritoneal cavity , 2001, Current opinion in critical care.

[53]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[54]  C. Holmes.  Peritoneal Host Defense Mechanisms , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[55]  R. Holzheimer,et al.  Intraabdominal infections: Classification, mortality, scoring and pathophysiology , 1991, Infection.

[56]  J. Paulson,et al.  Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. , 1989, The Journal of biological chemistry.

[57]  R. Dwek,et al.  Cell-type-specific and site-specific N-glycosylation of type I and type II human tissue plasminogen activator. , 1989, Biochemistry.

[58]  K. Terayama,et al.  A LIPID METABOLIC DISEASE —“MEMBRANOUS LIPODYSTROPHY”— AN AUTOPSY CASE DEMONSTRATING NUMEROUS PECULIAR MEMBRANE‐STRUCTURES COMPOSED OF COMPOUND LIPID IN BONE AND BONE MARROW AND VARIOUS ADIPOSE TISSUES , 1973, Acta pathologica japonica.

[59]  P. Sourander,et al.  OSTEODYSPLASIA POLYCYSTICA HEREDITARIA COMBINED WITH SCLEROSING LEUCOENCEPHALOPATHY , 1970, Acta neurologica Scandinavica.

[60]  H. K. Bourns.  Management of Sepsis , 1960, The Medical journal of the South-West.

[61]  M. Colonna,et al.  The enigmatic function of TREM-2 in osteoclastogenesis. , 2007, Advances in experimental medicine and biology.

[62]  P. Henson.  Dampening inflammation , 2005, Nature Immunology.

[63]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.